Literature DB >> 9422934

In vivo immunofluorescence to diagnose herpes simplex virus keratitis in mice.

A Sharma1, C Shimeld.   

Abstract

BACKGROUND/AIMS: Herpes simplex virus keratitis (HSK) is the most common cause of corneal blindness in the Western world. Delay in the treatment of HSK can lead to a more significant corneal scar and topical steroid treatment in unsuspected active HSK can lead to corneal melting. Current culture techniques for herpes simplex virus (HSV) take several days and commercially available HSV laboratory based diagnostic techniques such as Herpchek vary in sensitivity. This study was conducted to assess the viability of a new, quicker, and simpler method to diagnose HSK.
METHODS: Direct immunofluorescence was used in vivo in a masked study to diagnose HSK in mice using a standard slit lamp with cobalt blue illumination. Murine monoclonal fluorescently labelled antibody was applied to the cornea for 10 or 20 minutes and then washed off with phosphate buffered solution. Mice with HSK were stained with either fluorescently labelled monoclonal antibody against HSV or fluorescently labelled monoclonal antibody against cytomegalovirus. Mice with corneal abrasions of non-viral origin were given fluorescently labelled monoclonal antibody against HSV.
RESULTS: Fluorescence was seen only in the mice with HSK given fluorescently labelled monoclonal antibody against HSV. This observation was confirmed upon microscopic immunofluorescent imaging of the corneal epithelial sheets.
CONCLUSION: In vivo immunofluorescence may be useful in the clinical diagnosis of HSK.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422934      PMCID: PMC1722311          DOI: 10.1136/bjo.81.9.785

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  THYGESON'S SUPERFICIAL PUNCTATE KERATITIS.

Authors:  B R JONES
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  Intraocular in vivo immunofluorescence. A new technique for visualizing structures of the ocular fundus.

Authors:  O F Scheiffarth; E Zrenner; R Disko; F H Stefani; B Brabänder
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-02       Impact factor: 4.799

3.  Dendritic corneal lesions associated with soft contact lens wear.

Authors:  L J Margulies; M J Mannis
Journal:  Arch Ophthalmol       Date:  1983-10

4.  Antigens of herpes simplex virus in whole corneal epithelial sheets from mice.

Authors:  C Shimeld; S J Lewkowicz-Moss; K M Lipworth; T J Hill; W A Blyth; D L Easty
Journal:  Arch Ophthalmol       Date:  1986-12

5.  Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.

Authors:  C Shimeld; T J Hill; W A Blyth; D L Easty
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

6.  Evaluation of immunologic tests for the detection of ocular herpes simplex virus.

Authors:  R P Kowalski; Y J Gordon
Journal:  Ophthalmology       Date:  1989-11       Impact factor: 12.079

7.  Corneal transplantation in the United Kingdom and Republic of Ireland.

Authors:  A Vail; S M Gore; B A Bradley; D L Easty; C A Rogers
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

8.  A comparison of enzyme immunoassay and polymerase chain reaction with the clinical examination for diagnosing ocular herpetic disease.

Authors:  R P Kowalski; Y J Gordon; E G Romanowski; T Araullo-Cruz; P R Kinchington
Journal:  Ophthalmology       Date:  1993-04       Impact factor: 12.079

9.  Ocular infection with herpes simplex virus in nonimmune and immune mice.

Authors:  A B Tullo; C Shimeld; W A Blyth; T J Hill; D L Easty
Journal:  Arch Ophthalmol       Date:  1983-06

10.  Pseudodendritic keratitis and systemic tyrosinemia.

Authors:  K H Charlton; P S Binder; L Wozniak; D J Digby
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

  10 in total
  1 in total

1.  Ex vivo organotypic corneal model of acute epithelial herpes simplex virus type I infection.

Authors:  Oleg Alekseev; Anh H Tran; Jane Azizkhan-Clifford
Journal:  J Vis Exp       Date:  2012-11-03       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.